Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Ebert

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Biological Psychiatry|July 27, 1999
Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeysA S Clarke, M H Ebert, D E Schmidt, et al.
Archives of General Psychiatry|February 1, 1978
Probenecid-induced norepinephrine elevations in plasma and CSFC R Lake, J H Wood, M G Ziegler, et al.
Biological Psychiatry|January 1, 1988
CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gainW H Kaye, H E Gwirtsman, D T George, et al.
Annals of Neurology|March 1, 1979
Trial of chlorimipramine and desipramine for Gilles de la Tourette syndromeE D Caine, R J Polinsky, M H Ebert, et al.
Psychopharmacology|April 11, 1979
Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responsesG L Brown, R D Hunt, M H Ebert, et al.
Neurotoxicology and Teratology|July 1, 1993
Lack of effect of chronic developmental lead treatment on biogenic amines and metabolites in monkey cerebrospinal fluidS A Ferguson, G W Kraemer, R E Bowman, et al.
Pharmacopsychiatry|January 1, 1984
Disposition and metabolism of MHPG in humans: application to studies in depressionI J Kopin, D C Jimerson, S P Markey, et al.
Neurology|January 1, 1979
Hypoxanthine guanine phosphoribosyltransferase (HGPRT) in Gilles de la Tourette syndromeC R Merril, J Leavitt, M L Van Keuren, et al.
Archives of General Psychiatry|October 1, 1980
Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPGP A Blombery, I J Kopin, E K Gordon, et al.
Journal of Neurochemistry|March 1, 1977
Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrineM G Ziegler, C R Lake, J H Wood, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Biological Psychiatry|July 27, 1999
Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeysA S Clarke, M H Ebert, D E Schmidt, et al.
Archives of General Psychiatry|February 1, 1978
Probenecid-induced norepinephrine elevations in plasma and CSFC R Lake, J H Wood, M G Ziegler, et al.
Biological Psychiatry|January 1, 1988
CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gainW H Kaye, H E Gwirtsman, D T George, et al.
Annals of Neurology|March 1, 1979
Trial of chlorimipramine and desipramine for Gilles de la Tourette syndromeE D Caine, R J Polinsky, M H Ebert, et al.
Psychopharmacology|April 11, 1979
Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responsesG L Brown, R D Hunt, M H Ebert, et al.
Neurotoxicology and Teratology|July 1, 1993
Lack of effect of chronic developmental lead treatment on biogenic amines and metabolites in monkey cerebrospinal fluidS A Ferguson, G W Kraemer, R E Bowman, et al.
Pharmacopsychiatry|January 1, 1984
Disposition and metabolism of MHPG in humans: application to studies in depressionI J Kopin, D C Jimerson, S P Markey, et al.
Neurology|January 1, 1979
Hypoxanthine guanine phosphoribosyltransferase (HGPRT) in Gilles de la Tourette syndromeC R Merril, J Leavitt, M L Van Keuren, et al.
Archives of General Psychiatry|October 1, 1980
Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPGP A Blombery, I J Kopin, E K Gordon, et al.
Journal of Neurochemistry|March 1, 1977
Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrineM G Ziegler, C R Lake, J H Wood, et al.
Pageof 14